Vectored thermal pulsation tops January cornea coverage
A method to improve meibomian gland structure and complications after amniotic membrane transplantation led January’s cornea/external disease coverage.
Read the month’s best-performing cornea articles from Healio/OSN below.
Vectored thermal pulsation improves visible meibomian gland structure
Eyes with meibomian gland dysfunction treated with vectored thermal pulsation experienced improved visible meibomian gland structure compared with eyes in a nontreatment control group. Read more.
Managing ocular sequelae after amniotic membrane transplantation ‘paramount’
Cornea and eyelid margin complications were common after amniotic membrane transplantation for acute manifestations of Stevens-Johnson syndrome/toxic epidermal necrolysis. Read more.
Sore eyes a significant ocular manifestation of COVID-19
Sore eyes represent a significant ocular symptom in patients with COVID-19, according to a study published in BMJ Open Ophthalmology. Read more.
Kala launches Eysuvis for short-term dry eye treatment
Eysuvis uses Kala’s proprietary Ampplify mucus-penetrating particle drug delivery technology for enhanced penetration of loteprednol etabonate into target ocular surface tissue to treat signs and symptoms of dry eye disease. Read more.
Positive topline results reported in run-in cohort of reproxalap phase 3 trial
Reproxalap demonstrated statistically significant improvements in dry eye symptoms, redness and Schirmer’s test results compared with vehicle in a run-in cohort of the phase 3 TRANQUILITY clinical trial. Read more.